AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)
Clinical trials for AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA) explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA) trials appear
Sign up with your email to follow new studies for AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to tame stubborn blood disorders
Disease control Not yet recruitingThis early-phase study tests whether combining two drugs (Zuberitamab and Orelabrutinib) can help people with immune thrombocytopenia (ITP) or autoimmune hemolytic anemia (AIHA) that hasn't responded to other treatments. The drugs work together to calm the immune system and stop …
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)
Phase: PHASE1 • Sponsor: Qi deng • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New combo aims to tame autoimmune anemia without Long-Term steroids
Disease control Not yet recruitingThis study tests whether adding sirolimus to standard steroid treatment helps people with newly diagnosed mild autoimmune hemolytic anemia (AIHA) achieve lasting remission. About 216 adults will be randomly assigned to get either steroids alone or steroids plus sirolimus for 6 mo…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)
Phase: NA • Sponsor: Chen Miao • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC